BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
LEP
,
glucose metabolic process
,
Pseudomonas infection
,
Lung
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
drug m
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate adenocarcinoma LNCaP cells treated with dihydrotestosterone in different cell cycle phases
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Drug target sets for approved compounds
Bladder cancer subsets expression profile analysis
Explore Curated Studies Results
Literature
Most Relevant Literature
Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis.
Simultaneous Determination of 147 Pesticide Residues in Traditional Chinese Medicines by GC-MS/MS.
Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in brea…
Editorial: New Approaches Against Drug-Resistant M. tuberculosis.
Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and…
The Individualized M(X) Drug-resistant TB Treatment Strategy Study
Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-V…
Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg
The ONE Study M Reg Trial
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ